logo
Select company
Select metric
$ -10.56MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
25
Sector
60
Industry
76
History
9
$ 0.18Close
$ 0.16 - $ 11.69 52-Week Range
Ticker Information

Ticker

ABP

Company Name

ABPRO HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ABPRO HOLDINGS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ABP - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 588K$ -11.14M$ -10.56M
3/31/2025$ 774K$ -8.95M$ -8.18M
12/31/2024$ 622K$ -6.84M$ -6.22M
9/30/2024$ 1.27M$ -19.32M$ -18.06M
6/30/2024$ 0$ -1.23M$ -1.23M
3/31/2024$ 0$ 203.81K$ 203.81K
12/31/2023$ 0$ 4M$ 4M
9/30/2023$ 0$ 6.04M$ 6.04M
6/30/2023$ 0$ 6.8M$ 6.8M
3/31/2023$ 0$ 5.49M$ 5.49M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ABPRO HOLDINGS INC's latest trailing twelve months (TTM) EBITDA stands at $ -1.79K.
  • Over the past 5 years, ABPRO HOLDINGS INC's average EBITDA has been $ -1.67M.
  • The median EBITDA for ABPRO HOLDINGS INC during this period was $ 101.01K
  • ABPRO HOLDINGS INC reached its highest EBITDA over the past 5 years at $ 6.8M.
  • The lowest EBITDA recorded by ABPRO HOLDINGS INC in the same timeframe $ -18.06M

ABPRO HOLDINGS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
SABS : SAB BIOTHERAPEUTICS INC $ -33.47MHCWB : HCW BIOLOGICS INC $ -8.92MNXL : NEXALIN TECHNOLOGY INC $ -8.84MCTXR : CITIUS PHARMACEUTICALS INC $ -38.95MLIXT : LIXTE BIOTECHNOLOGY HOLDINGS INC $ -3.08MCVKD : CADRENAL THERAPEUTICS INC $ -14.1MVIVS : VIVOSIM LABS INC $ -1.17MAIM : AIM IMMUNOTECH INC $ -14.93MBCTX : BRIACELL THERAPEUTICS CORP $ 4.41MBGMS : BIO GREEN MED SOLUTION INC $ -5.45M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for ABPRO HOLDINGS INC is calculated as follows: EBIT [ $ -1.79K ] + DepAmor [ $ 0 ]
(=) EBITDA [ $ -1.79K ]

ABP - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -18.06M

Minimum

Sep 30, 2024

$ 6.8M

Maximum

Jun 30, 2023

$ -1.67M

Average

$ 101.01K

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.9M with a standard deviation of $ 167.01M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -493.3M
max$ 590.6M
average$ 58.9M
median$ 8.92M
std$ 167.01M